About half of patients with asthma on tezepelumab had discontinued their daily maintenance oral corticosteroid doses by 52 ...

Experts say this nutrient supports healthy lungs and may reduce asthma attacks. Key PointsAsthma is a common condition, ...

Remote study conducted at Rutgers and elsewhere finds albuterol-budesonide mix cuts risk for mild cases and may let patients ...

In severe asthma, most patients who seek acute care do so due to symptom severity and need for rapid care when rescue ...

AstraZeneca presented data from the phase 3 BATURA study which showed that use of Airsupra in those with mild asthma reduced ...

Tezepelumab, a monoclonal antibody targeting TSLP approved for add-on severe asthma treatment in 2021, had been associated ...

Since the European Medicines Agency (EMA) approval of omalizumab in 2005 as the first ever biologic for severe asthma, the ...

The study evaluated 807 adults who initiated an anti–IL–5 therapy (79% mepolizumab, 21% benralizumab) between 2017 and 2020.